Live donor adult liver transplantation

Current Opinion in Organ Transplantation

Volumn 13, Issue 3, 2008, Pages 241-246

  Yeh, Heidi ^a   Olthoff, Kim M ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Donor morbidity; Liver transplantation; Living donor; Posttransplant outcome

Indexed keywords

BILE DUCT CARCINOMA; BILE LEAKAGE; BLEEDING; CLINICAL EVALUATION; COMPARATIVE STUDY; DEPRESSION; DONOR SELECTION; HEPATITIS C; HUMAN; INCISIONAL HERNIA; INFECTION; INFORMED CONSENT; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONOR; MORBIDITY; MORTALITY; ORGAN DONOR; OUTCOME ASSESSMENT; PLEURA EFFUSION; RECIPIENT; REVIEW; SCREENING; ADULT; PATIENT SELECTION; TREATMENT OUTCOME;

ADULT; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 54549083244     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328300a352     Document Type: Review

References (46)

1. Pomfret EA, Fryer JP, Sima CS, et al. Liver and intestine transplantation in the United States, 1996-2005. Am J Transplantation 2007; 7:1376-1389. This paper is a yearly review of all national data from the Scientific Registry of Transplant Recipients.
2. 2006 OPTN/SRTR Annual Report: Transplant Data 1996-2005. US Department of Health and Human Services. www.optn.org/AR2006/default.htm. [Accessed 25 March 2008]
3. Barr ML, Belghiti J, Villamil FG, et al. A report of the Vancouver forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation 2006; 81:1373-1385. This paper is a report of the first multinational forum on the care and safety of the living donor.
4. Florman S, Miller CM. Live donor liver transplantation. Liver Transpl 2006; 12:499-510.
5. Trotter JF, Hayashi PJ, Kam I. Donor and recipient evaluation for adult-to adult right hepatic lobe liver transplantation. In: Busuttil RW, Klintmalm GB, editors. Transplantation of the liver. Philadelphia: Elsevier; 2005. pp. 655-674.
6. Trotter JF, Wisniewski KA, Terrault NA, et al., and the A2ALL Study Group. Outcomes of living donor evaluation in adult-to-adult living donor liver transplantation. Hepatology 2007; 46:1476-1484.
7. Centers for Medicare and Medicaid Services. Transplant. US Department of Health and Human Services; 26 February 2008. http://www.cms.hhs.gov/ CertificationandComplianc/20-Transplant.asp. [Accessed 15 March 2008]
8. Low G, Wiebe E, Walji AH, Bigam DL. Imaging evaluation of potential donors in living-donor liver transplantation. Clin Radiol 2008; 63:136-145.
9. Tran TT, Changsri C, Shackleton CR, et al. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. Gastroenterol Hepatol 2006; 21:381-383.
10. Yamamoto K, Takada Y, Fujimoto Y, et al. Nonalcoholic steatohepatitis in donors for living donor liver transplantation. Transplantation 2007; 83:257.
11. Pomfret EA, Feng S. Striving for perfection: evaluation of the right lobe liver live donor. Liver Transpl 2006; 6:1755-1756.
12. Celebi Kobak A, Karasu Z, Kilic M, et al. Living donor liver transplantation from hepatitis B core antibody positive donors. Transplant Proc 2007; 39:1488- 1490.
13. Lo CM, Fan ST, Liu CL, et al. Safety and outcome of hepatitis B core antibodypositive donors in right-lobe living donor liver transplantation. Liver Transpl 2003; 9:827-832.
14. Nadalin S, Malagò M, Radtke A, et al. Current trends in live liver donation. Transpl Int 2007; 20:312-330.
15. Eghtsead B, Miller CM. Extended follow-up of extended right lobe living donors: when is enough enough? Liver Transpl 2006; 12:199-200.
16. Chan SC, Fan ST, Lo CM, et al. Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases. Ann Surg 2007; 245:110-117.
17. Ghobrial RM, Freise CE, Trotter JF, et al., A2ALL Study Group. Donor morbidity and mortality of adult living donors for liver transplantation [abstract]. Am J Transplant 2006; 6 (Suppl 2):115.
18. Middleton PF,Duffield M, Lynch SV, et al. Living donor liver transplantation: adult donor outcomes. A systematic review. Liver Transpl 2006; 12:199-200.
19. Morioka D, Egawa H, Kasahara M, et al. Outcomes of adult-to-adult live donor liver transplantation. Ann Surg 2007; 245:315-325.
20. Pompeselli J, Verbesey J, Simpson MA, et al. Improved survival after live donor adult liver transplantation using right lobe grafts: program experience and lessons learned. Am J Transplant 2006; 6:589-598.
21. Patel S, Orloff M, Tsoulfas G, et al. Living-donor liver transplantation in the United States: identifying donors at risk for perioperative complications. Am J Transplant 2007; 7:2344-2349.
22. Siegler M, Simmerling MC, Siegler JH, Cronin DC. Recipient deaths during donor surgery: a new ethical problem in living donor liver transplantaion (LDLT). Liver Transpl 2006; 12:358-360.
23. Trotter JF, Adam R, Lo CM, Kenison J. Documented deaths of hepatic lobe donors for livingdonor liver transplantation. Liver Transpl2006;12:1443-1444. This paper is a thorough discussion of all the documented and reported deaths in adult living liver donors across the globe.
24. Bramstedt KA. Living donor mortality; where do we stand? Am J G 2006; 101:755-759.
25. Nadalin S, Malago M, Testa G, et al. ''Hepar Divisum'': as a rare donor complication after intraoperative mortality of the recipient of an intended living donor liver transplantation. Liver Transpl 2006; 12:428-434.
26. Siegler J, Siegler M, Cronin DC II. Recipient death during a live donor liver transplantation: who gets the ''orphan'' graft? Transplantation 2004; 78: 1241-1244.
27. Wachs M, Trotter J. The appropriate allocation of ''orphan graft'' in living donor liver transplantation: simple solutions to a complex problem. Liver Transpl 2006; 12:361-362.
28. Transplant Living. Living donation. UNOS; 2008. http://www. transplantliving. org/livingdonation/default.aspx. [Accessed 25 March 2008]
29. Olthoff KM, Merion RM, Ghobrial RM, et al., and the A2ALL Study Group. Outcomes of 385 adult-to-adult living donor liver transplant recipients. Ann Surg 2005; 242:314-325.
30. Berg CL, Gillespie BW, Merion RM, et al., A2ALL Study Group. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 2007; 133:1806-1813. This important retrospective analysis from A2ALL compared outcomes of recipients of living donor grafts to those of deceased donor grafts, fromthe time of identification of a donor. Improved survival is seen from decreasing death on the waitlist.
31. Shah SA, Levy GA, Greig PD, et al. Reduced mortality with right lobe living donor compared to deceased donor liver transplantation when analyzed from time of listing. Am J Transplant 2007; 7:998-1002.
32. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2005; 5:307-313.
33. Abt PL, Mange KC, Olthoff KM, et al. Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 2004; 4:1302-1307.
34. Sarasin FP, Majno PE, Llovet JM, et al. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology 2001; 33:1073-1079.
35. Volk ML, Marrero JA, Lok AS, Ubel PA. Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma. Transplantation 2006; 82:1136-1139.
36. Yao FY, Xiao L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: validation of UCSF criteria based on preoperative imaging. Am J Transpl 2007; 7:2587-2596.
37. Fisher RA, Kulik LM, Freise CE, et al., A2ALL Study Group. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007; 7:1601-1608.
38. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005; 242:451-461.
39. Gores G, Gish RG, Sudan D, Rosen CB. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl 2006; 12:S95-S97.
40. Pandey D, Lee K-H, Tan K-C. The role of liver transplantation for hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2007; 6:248-253.
41. Thuluvath PJ, Krok KL, Segev DL, Yoo HY. Trends in postliver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States. Liver Transpl 2007; 13:719-724.
42. Gaglio PJ, Malireddy S, Levitt BS, et al. Increased risk of cholestatic hepatitis C in recipients of grafts from living vs. cadaveric liver donors. Liver Transpl 2003; 9:1028-1035.
43. Garcia-Retortillo M, Forns X, Llovet JM, et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004; 40:699-707.
44. Lawai A, Ghobrial R, Te H, et al. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation. Transplant Proc 2007; 39:3261-3265.
45. Schmeding M, Neumann UP, Puhl G, et al. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients. Liver Transpl 2007; 13:687- 692.
46. Terrault NA, Shiffman ML, Lok AS, et al., and the A2ALL Study Group. Outcomes in hepatic C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl 2007; 13:122-129. This important study compared outcomes between living donor and deceased donors in the hepatitis C population.